202 related articles for article (PubMed ID: 15161649)
21. An autopsy case of neuronal intermediate filament inclusion disease with regard to immunophenotypic and topographical analysis of the neuronal inclusions.
Inoue K; Fujimura H; Ueda K; Matsumura T; Itoh K; Sakoda S
Neuropathology; 2015 Dec; 35(6):545-52. PubMed ID: 26096780
[TBL] [Abstract][Full Text] [Related]
22. Extending the clinicopathological spectrum of neurofilament inclusion disease.
Josephs KA; Uchikado H; McComb RD; Bashir R; Wszolek Z; Swanson J; Matsumoto J; Shaw G; Dickson DW
Acta Neuropathol; 2005 Apr; 109(4):427-32. PubMed ID: 15754170
[TBL] [Abstract][Full Text] [Related]
23. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation.
Shi J; Shaw CL; Du Plessis D; Richardson AM; Bailey KL; Julien C; Stopford C; Thompson J; Varma A; Craufurd D; Tian J; Pickering-Brown S; Neary D; Snowden JS; Mann DM
Acta Neuropathol; 2005 Nov; 110(5):501-12. PubMed ID: 16222525
[TBL] [Abstract][Full Text] [Related]
24. PRKAR1B mutation associated with a new neurodegenerative disorder with unique pathology.
Wong TH; Chiu WZ; Breedveld GJ; Li KW; Verkerk AJ; Hondius D; Hukema RK; Seelaar H; Frick P; Severijnen LA; Lammers GJ; Lebbink JH; van Duinen SG; Kamphorst W; Rozemuller AJ; ; Bakker EB; ; Neumann M; Willemsen R; Bonifati V; Smit AB; van Swieten J
Brain; 2014 May; 137(Pt 5):1361-73. PubMed ID: 24722252
[TBL] [Abstract][Full Text] [Related]
25. alpha-Internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the beta-amyloid plaques in inducing neuronal injury.
Dickson TC; Chuckowree JA; Chuah MI; West AK; Vickers JC
Neurobiol Dis; 2005 Mar; 18(2):286-95. PubMed ID: 15686957
[TBL] [Abstract][Full Text] [Related]
26. Neurodegeneration with features of NIFID and ALS--extended clinical and neuropathological spectrum.
Roeber S; Bäzner H; Hennerici M; Porstmann R; Kretzschmar HA
Brain Pathol; 2006 Jul; 16(3):228-34. PubMed ID: 16911480
[TBL] [Abstract][Full Text] [Related]
27. Compartmentation of alpha-internexin and neurofilament triplet proteins in cultured hippocampal neurons.
Benson DL; Mandell JW; Shaw G; Banker G
J Neurocytol; 1996 Mar; 25(3):181-96. PubMed ID: 8737171
[TBL] [Abstract][Full Text] [Related]
28. Screening for neurofilament inclusion disease using alpha-internexin immunohistochemistry.
Uchikado H; Shaw G; Wang DS; Dickson DW
Neurology; 2005 May; 64(9):1658-9. PubMed ID: 15883343
[No Abstract] [Full Text] [Related]
29. Spatial patterns of the pathological changes in the temporal lobe of patients with neuronal intermediate filament inclusion disease.
Cairns NJ; Armstrong RA
Neuropathology; 2005 Dec; 25(4):298-303. PubMed ID: 16382778
[TBL] [Abstract][Full Text] [Related]
30. Spatial correlations between the neuronal inclusions, swollen achromatic neurons, and glial cells in neuronal intermediate filament inclusion disease (NIFID).
Cairns NJ; Armstrong RA
J Neural Transm (Vienna); 2005 Apr; 112(4):473-80. PubMed ID: 15375676
[TBL] [Abstract][Full Text] [Related]
31. No requirement of alpha-internexin for nervous system development and for radial growth of axons.
Levavasseur F; Zhu Q; Julien JP
Brain Res Mol Brain Res; 1999 May; 69(1):104-12. PubMed ID: 10350642
[TBL] [Abstract][Full Text] [Related]
32. Alpha-internexin is structurally and functionally associated with the neurofilament triplet proteins in the mature CNS.
Yuan A; Rao MV; Sasaki T; Chen Y; Kumar A; Veeranna ; Liem RK; Eyer J; Peterson AC; Julien JP; Nixon RA
J Neurosci; 2006 Sep; 26(39):10006-19. PubMed ID: 17005864
[TBL] [Abstract][Full Text] [Related]
33. The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein.
Taniguchi S; McDonagh AM; Pickering-Brown SM; Umeda Y; Iwatsubo T; Hasegawa M; Mann DM
Neuropathol Appl Neurobiol; 2004 Feb; 30(1):1-18. PubMed ID: 14720172
[TBL] [Abstract][Full Text] [Related]
34. α-Internexin and Peripherin: Expression, Assembly, Functions, and Roles in Disease.
Zhao J; Liem RK
Methods Enzymol; 2016; 568():477-507. PubMed ID: 26795481
[TBL] [Abstract][Full Text] [Related]
35. Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions.
Cairns NJ; Perry RH; Jaros E; Burn D; McKeith IG; Lowe JS; Holton J; Rossor MN; Skullerud K; Duyckaerts C; Cruz-Sanchez FF; Lantos PL
Neurosci Lett; 2003 May; 341(3):177-80. PubMed ID: 12697277
[TBL] [Abstract][Full Text] [Related]
36. [Nosology of dementias: the neuropathologist's point of view].
Duyckaerts C
Rev Neurol (Paris); 2006 Oct; 162(10):921-8. PubMed ID: 17028559
[TBL] [Abstract][Full Text] [Related]
37. [Pathology of the cytoskeleton in Alzheimer's disease and disorders related to this disease].
Seitelberg F; Lassmann H
Gac Med Mex; 1990; 126(5):367-73. PubMed ID: 1966495
[TBL] [Abstract][Full Text] [Related]
38. alpha-Internexin is the only neuronal intermediate filament expressed in developing cerebellar granule neurons.
Chien CL; Mason CA; Liem RK
J Neurobiol; 1996 Mar; 29(3):304-18. PubMed ID: 8907160
[TBL] [Abstract][Full Text] [Related]
39. Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments.
Ching GY; Liem RK
J Cell Biol; 1993 Sep; 122(6):1323-35. PubMed ID: 8376465
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneous inclusions in neurofilament inclusion disease.
Uchikado H; Li A; Lin WL; Dickson DW
Neuropathology; 2006 Oct; 26(5):417-21. PubMed ID: 17080718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
